170 related articles for article (PubMed ID: 15642292)
41. Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis.
Capello D; Rossi D; Gaidano G
Hematol Oncol; 2005 Jun; 23(2):61-7. PubMed ID: 16216037
[TBL] [Abstract][Full Text] [Related]
42. Post-transplant lymphoproliferative disorder with supraglottic involvement.
Rombaux P; Marque A; Hamoir M; Smets F; Sokal E
B-ENT; 2005; 1(1):53-6. PubMed ID: 15999677
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
[TBL] [Abstract][Full Text] [Related]
44. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome.
Fernández MC; Bes D; De Dávila M; López S; Cambaceres C; Dip M; Imventarza O
Pediatr Transplant; 2009 May; 13(3):307-10. PubMed ID: 18346039
[TBL] [Abstract][Full Text] [Related]
45. Post-transplant lymphoproliferative disorders.
Patel PR
Clin Oncol (R Coll Radiol); 1999; 11(2):118-22. PubMed ID: 10378638
[TBL] [Abstract][Full Text] [Related]
46. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.
Knoop C; Kentos A; Remmelink M; Garbar C; Goldman S; Feremans W; Estenne M
Clin Transplant; 2006; 20(2):179-87. PubMed ID: 16640524
[TBL] [Abstract][Full Text] [Related]
47. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.
Cullis B; D'Souza R; McCullagh P; Harries S; Nicholls A; Lee R; Bingham C
Am J Kidney Dis; 2006 May; 47(5):e67-72. PubMed ID: 16632009
[TBL] [Abstract][Full Text] [Related]
48. Primary central nervous system posttransplantation lymphoproliferative disorder in an elderly liver transplant recipient.
Dahiya S; Ooi WB; Ahluwalia MS; Asik A
J Am Geriatr Soc; 2012 Sep; 60(9):1777-8. PubMed ID: 22985151
[No Abstract] [Full Text] [Related]
49. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.
Elidemir O; Kancherla BS; Schecter MG; McKenzie ED; Morales DL; Heinle JS; Mallory GB
Pediatr Transplant; 2009 Aug; 13(5):606-10. PubMed ID: 19017289
[TBL] [Abstract][Full Text] [Related]
50. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
[TBL] [Abstract][Full Text] [Related]
51. Immunosuppressed solid organ transplant recipient.
Stine JG; Shah N; Argo C
Gastroenterology; 2014 Feb; 146(2):345,590. PubMed ID: 24342810
[No Abstract] [Full Text] [Related]
52. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
53. Post-transplant lymphoproliferative disorders: from treatment to early detection and prevention?
Bakker NA; van Imhoff GW
Haematologica; 2007 Nov; 92(11):1447-50. PubMed ID: 18024391
[No Abstract] [Full Text] [Related]
54. Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
Choquet S; Oertel S; LeBlond V; Riess H; Varoqueaux N; Dörken B; Trappe R
Ann Hematol; 2007 Aug; 86(8):599-607. PubMed ID: 17522862
[TBL] [Abstract][Full Text] [Related]
55. Post-transplant lymphoproliferative disorder following renal transplant.
Woodfield CA
Med Health R I; 2007 Mar; 90(3):101. PubMed ID: 17601295
[No Abstract] [Full Text] [Related]
56. Unusual manifestation of posttransplant lymphoproliferative disorder in the esophagus.
Kranz B; Vester U; Becker J; Woltering T; Wingen AM; Paul A; Hoyer PF
Transplant Proc; 2006 Apr; 38(3):693-6. PubMed ID: 16647447
[TBL] [Abstract][Full Text] [Related]
57. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
58. Native kidney post-transplant lymphoproliferative disorder in a non-renal transplant patient.
Araya CE; Mehta MB; González-Peralta RP; Hunger SP; Dharnidharka VR
Pediatr Transplant; 2009 Jun; 13(4):495-8. PubMed ID: 18673359
[TBL] [Abstract][Full Text] [Related]
59. Abdominal manifestations of posttransplantation lymphoproliferative disorder.
Pickhardt PJ; Siegel MJ
AJR Am J Roentgenol; 1998 Oct; 171(4):1007-13. PubMed ID: 9762986
[TBL] [Abstract][Full Text] [Related]
60. Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder.
Barth RN; Nam AJ; Stanwix MG; Kukuruga D; Drachenberg CI; Bluebond-Langner R; Hui-Chou H; Shipley ST; Bartlett ST; Rodriguez ED
Transplantation; 2009 Dec; 88(11):1242-50. PubMed ID: 19996923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
